Doctor of Philosophy in Pathology and Laboratory Medicine (PhD)

Overview

The UBC Department of Pathology and Laboratory Medicine offers a remarkable opportunity to study with numerous world renowned faculty and research programs. We are recognized as national and international leaders in both basic and clinical research. Experimental Pathology refers to research in any area of biomedical investigation that is relevant to human disease. Since it is necessary to understand the normal working of the system to fully define the changes associated with disease, the areas represented at UBC cover a wide range of fields and approaches. Work at all levels of biological organization is involved, from protein to lipoprotein biochemistry and molecular biology through cell and tumour biology, animal models for studies on pulmonary and cardiovascular pathophysiology and viral and bacterial infection processes, to clinical studies on human population and the AIDS epidemic.

We train students with varied backgrounds in science and medicine including: biochemistry, physiology, cell biology and microbiology/immunology.

We are committed to effective, cutting-edge, ethical research. The results of which will reach beyond the academic realm to effect positive change in the lives of our families, communities and, ultimately, our world.

Quick Facts

Degree
Doctor of Philosophy
Subject
Life Sciences
Mode of delivery
On campus
Registration options
Full-time
Specialization
Pathology and Laboratory Medicine
Program Components
Dissertation
Faculty
Faculty of Medicine

Apply Now

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.

Meet a UBC representative

Q&A with UBC Graduate Student Ambassadors

webinar
Date: Thursday, 23 August 2018
Time: 09:00 to 10:00
Join our Graduate Student Ambassadors Samuel Adenyanju (MSc Forestry, Nigeria), Federico Andrade (PhD Public Health, Colombia), Maria Angélica Guerrero (MA Educational Studies, Colombia), Xining (Linda) Yang (PhD Pathology and Laboratory Medicine, China) and Dorine Akwiri (Master of Public Policy and Global Affairs, Kenya) who will be available to answer questions about their experiences at UBC, including topics such as accommodation, moving to a new city/province/country and settling in, making friends, being an international student, and more. This session is open to participants interested in different programs across all faculties at UBC. Please note that we will not be able to provide answers to questions regarding application or admissions policies or any that involve specific personal information.

Requirements

TOEFL (ibT) Overall Score Requirement

100
22
21
22
21

IELTS Overall Score Requirement

7.0
6.5
6.5
6.5
6.5

Supervisor commitment required prior to application?

Yes

GRE required?

Required by some applicants (check program website)

Funding Sources

All full-time students who begin a UBC-Vancouver PhD program in September 2018 or later will be provided with a funding package of at least $18,000 for each of the first four years of their PhD. The funding package may consist of any combination of internal or external awards, teaching-related work, research assistantships, and graduate academic assistantships. Please note that many graduate programs provide funding packages that are substantially greater than $18,000 per year. Please check with your prospective graduate program for specific details of the funding provided to its PhD students.

Career Outcomes

85 students graduated between 2005 and 2013: 1 graduate is seeking employment; for 8 we have no data (based on research conducted between Feb-May 2016). For the remaining 76 graduates:


RI (Research-Intensive) Faculty: typically tenure-track faculty positions (equivalent of the North American Assistant Professor, Associate Professor, and Professor positions) in PhD-granting institutions
TI (Teaching-Intensive) Faculty: typically full-time faculty positions in colleges or in institutions not granting PhDs, and teaching faculty at PhD-granting institutions
Term Faculty: faculty in term appointments (e.g. sessional lecturers, visiting assistant professors, etc.)
Sample Employers in Higher Education
University of British Columbia (15)
McGill University (2)
University of Oslo
University of Nebraska at Omaha
Langara College
Queensland Medical Research Institute
University Hospital of Geneva
Gulbenkian Institute of Science
University of North Dakota
Harvard University
Sample Employers Outside Higher Education
STEMCELL Technologies (2)
BC Centre for Disease Control (2)
NO
Dorsey & Whitney
Network Immunology Inc.
PROOF Centre of Excellence
Panagin Pharmaceuticals Inc.
Tekmire Pharmaceutical Corporation
Therapeutic Effectiveness and Policy Bureau
Ottawa Hospital Research Institute
Sample Job Titles Outside Higher Education
Scientist (5)
Senior Scientist (3)
Postdoctoral Fellow (2)
Medical Science Liaison (2)
Research Scientist (2)
Research Associate (2)
Research Specialist
Science Director
Researcher, Pathologist
Biomarker Program Manager
PhD Career Outcome Survey
You may view the full report on career outcomes of UBC PhD graduates on outcomes.grad.ubc.ca.
Disclaimer
These data represent historical employment information and do not guarantee future employment prospects for graduates of this program. They are for informational purposes only. Data were collected through either alumni surveys or internet research.
Career Options

An Experimental Pathology degree opens up a world of opportunities. Because of the multidisciplinary nature of our program, graduates are working on research all over the world that is personalized to their interests. Our alumni have gone on to become national and international opinion leaders, valued staff researchers and administrators in academia or the biotechnology industry, studied clinical medicine or dived into the venture capital and equities domain.

Alumni on Success

Xin Ye

Job Title
Research Scientist
Employer
Arbutus Biopharma Inc.

Erin Tranfield

Job Title
Head of the Electron Microscopy Facility
Employer
Instituto Gulbenkian de Ciência

Tuition / Program Costs

FeesCanadian Citizen / Permanent Resident / Refugee / DiplomatInternational
Application Fee$102.00$165.00
Tuition *
Installments per year33
Tuition per installment$1,632.61$2,868.22
Tuition per year$4,897.83$8,604.66
Int. Tuition Award (ITA) per year (if eligible) $3,200.00 (-)
Other Fees and Costs
Student Fees (yearly)$923.38 (approx.)
Costs of living (yearly)starting at $16,884.10 (check cost calculator)
* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.

Statistical Data

Enrolment Data

 20172016201520142013
Applications361094
Offers13452
New registrations13442
Total enrolment4146474949

Completion Rates & Times

This program has a graduation rate of 87.5% based on 16 students admitted between 2004 - 2007. Based on 12 graduations between 2013 - 2016 the minimum time to completion is 3.66 years and the maximum time is 7.00 years with an average of 5.44 years of study. All calculations exclude leave times.
Disclaimer
Admissions data refer to all UBC Vancouver applications, offers, new registrants for each year, May to April [data updated: 9 March 2018]. Enrolment data are based on March 1 snapshots. Program completion data are only provided for datasets comprised of more than 4 individuals. Rates and times of completion depend on a number of variables (e.g. curriculum requirements, student funding), some of which may have changed in recent years for some programs [data updated: 29 September 2017].

Research Supervisors

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

  • Allard, Michael (Control of energy metabolism in normal and pathologic hearts; Physiologic and Pathologic Cardiac hypertrophy; Contribution of Metabolism to myocardial dysfunction after ischemia and reperfusion, especially in the setting of cardiac hypertrophy; Cardiovascular Pathology)
  • Aparicio, Samuel (Breast cancer, genome sequencing )
  • Bally, Marcel Bertran (Pancreas centre)
  • Bennewith, Kevin (Oncology; Molecular Pathology & Cell Biology; Cancer research; Solid tumour microenvironment; Hypoxia; Metastasis research; Pre-metastatic niche; Targeting hypoxic tumour cells in therapy; Radiation biology)
  • Brooks, Donald (microgravity research (space station, etc); diagnostic testing device; Centre for Blood Research; biomaterials, Organic chem, blood research)
  • Churg, Andrew (Lung disease)
  • Cimolai, Nevio (Infection control, ethics in hospital administration and public medical institutions)
  • Cote, Helene (HIV Infection, blood research, infectious diseases)
  • Daugaard, Mads (Cell Signaling and Cancer, Cancer Diagnosis and Detection, Stress and Cancer, Immunotherapy, Cell Therapy of Cancer, Chemotherapy, Radiotherapy, Cancer biology, Glycobiology, DNA damage response pathways, Cancer therapy, Cancer diagnostics, Stress signalling in cancer, Immunotherapy)
  • Devine, Dana Virginia (Biochemistry, blood regulation, platelet biology)
  • Devlin, Angela (obesity, children, cardiovascular disease, diabetes, developmental programming)
  • Gantt, Soren (cytomegalovirus, Burkitt’s lymphoma, Cytomegalovirus, epstein-barr virus, herpes simplex virus, congenital infection, newborn infection, Burkitt)
  • Gilks, Cyril Blake (Cancer of the Reproductive System, gynecological cancer diagnosis)
  • Granville, David (Aging Process, Skin Disorders, Auto-Immune Diseases, Aneurism, Connective Tissue Diseases, Cardiovascular Diseases, Chronic Diseases in Elderly, Proteases, Granzymes, Extracellular Matrix, Chronic inflammation, Aging, Disease models)
  • Huntsman, David (hereditary cancer, molecular pathology, cancer biomarkers, Pancreas centre)
  • Karsan, Aly (Myelodysplatic syndromes, myeloid malignancies, innate immune signaling in vascular hematopoietic function, genomics for clinical diagnostics)
  • Kelly, Niamh (science education from pre-school to university, balancing family and professional life, women in science, Children and babies, education, health care)
  • Kizhakkedathu, Jayachandran (Polymers, Biomaterials, Blood Coagulation, Macromolecular Therapeutics, Iron Chelators, Thrombosis, Cell-surface Engineering, Proteomics Tools, Implants and Medical Devices)
  • Krajden, Mel (Infectious diseases, cancer hepatitis prevention and care, human papillomavirus HPV, HIV and hepatitis C virus)
  • Krystal, Gerald (Blood research, immunology, inflammation, effect of diet on cancer )
  • Lam, Wan (Cancer progression; Genome biology; Epigenetics; Molecular Systems Biology; Lung Cancer; Technology Development)
  • Lange, Philipp (Cell Signaling and Cancer, Bioinformatics, Proteomics, pediatric cancer, post translational protein modification)
  • Laule, Cornelia (Imaging, Neurological Diseases, Neurodegenerative Diseases, Spinal Cord Diseases, Pathology, magnetic resonance imaging, brain, spinal cord, myelin, multiple sclerosis, spinal cord injury, neurological diseases)
  • Ling, Victor (Resistance to anticancer drugs, glycoprotein, chemotherapy, proteins )

Pages

Recent Doctoral Citations

  • Dr. Deborah Chen
    "Dr. Chen identified three membrane-associated proteins involved in antioxidant pathways as potential storage quality markers for red cell concentrates. These protein biomarkers hint at the role of oxidative damage in transfusion product quality deterioration. Her research also provided insight into the management and delivery of blood products." (May 2018)
  • Dr. Haoyu Deng
    "Dr. Deng developed a novel strategy to treat non-small-cell lung cancer (or NSCLC) using coxsackievirus type B3 (or CVB3). His studies demonstrated that CVB3 could specifically target and kill KRAS-mutant NSCLC, a non-curable subtype, with minimal damage to normal organs. This finding will aid in the development of oncolytic virotherapy for patients unable to have surgery." (May 2018)
  • Dr. Jonathan Kah Meng Lim
    "Dr. Lim uncovered a novel mechanism for how the cancer-causing gene K-RAS modulates antioxidant levels within cancer cells to protect them from damaging free radicals and in order to support cancer initiation and growth. This research presents a new therapeutic strategy for the treatment of difficult-to-treat cancers driven by K-RAS." (May 2018)
  • Dr. Wai Hang Cheng
    "Dr. Cheng developed a new clinically relevant experimental model of traumatic brain injury, which is now being used in different research laboratories. This new model has facilitated the study of the pathological development after concussions. This research illuminates the relationship between traumatic brain injuries and subsequent brain diseases." (May 2018)
  • Dr. Kyle Aaron Burrows
    "Dr. Burrows identified and characterized a vitamin A responsive transcription factor expressed in immune cells of the intestine and uncovered its role in the development of inflammatory bowel disease." (November 2017)

Sample Thesis Submissions

 

Apply Now

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
 

January 2019 Intake

Application Open Date
02 April 2018
Canadian Applicant Deadline
05 November 2018
International Applicant Deadline
01 October 2018

May 2019 Intake

Application Open Date
01 September 2018
Canadian Applicant Deadline
26 February 2019
International Applicant Deadline
29 December 2018

September 2019 Intake

Application Open Date
01 September 2018
Canadian Applicant Deadline
24 June 2019
International Applicant Deadline
01 April 2019

Program Information

Supervisor Search

 

Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update the application inquiries contact details please use this form.